Reporting adrs: contribution, knowledge and perception of german pharmacy professionals

  • At: 2018 FIP Congress in Glasgow (Scotland)
  • Type: Poster
  • By: LAVEN, Anna (Pharmabrain GmbH, Research and Training Center Berlin)
  • Co-author(s): Anna Laven
    Katharina Schmitz: Research and Training Center Berlin, Pharmabrain GmbH, Aachen, Germany
    Wilhelm-Hubertus Franzen: Takeda Pharma Vertrieb GmbH & Co. KG, Berlin, Germany
  • Abstract:

    Background

    The detection, assessment and prevention of adverse drug reactions after marketing authorisation is known as pharmacovigilance. German pharmacists are obliged by law to conduct pharmacovigilance measures, a specific training is not required.

    Methods

    A qualitative survey was conducted in November 2017. A questionnaire with 20 questions was

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login

FIP links